Volume 28, Issue 6 pp. 904-911
ORIGINAL ARTICLE

Association of vascular endothelial growth factor-C, plasma angiotensinogen and left ventricular hypertrophy in patients with hemodialysis

Haci Hasan Yeter

Corresponding Author

Haci Hasan Yeter

Department of Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey

Correspondence

Haci Hasan Yeter, Hacettepe University Faculty of Medicine, Department of Nephrology, Ankara, 06230, Turkey.

Email: [email protected]

Search for more papers by this author
Mustafa Levent

Mustafa Levent

Department of Geriatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey

Search for more papers by this author
Levent Sahiner

Levent Sahiner

Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey

Search for more papers by this author
Tolga Yildirim

Tolga Yildirim

Department of Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey

Search for more papers by this author
Rahmi Yilmaz

Rahmi Yilmaz

Department of Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey

Search for more papers by this author
First published: 18 June 2024

First and second authors are equal authors and both have equal contributions.

Abstract

Introduction

This study aims to examine the relationship between fluid overload, Vascular Endothelial Growth Factor C (VEGF-C), plasma Angiotensinogen (pAGT), and echocardiography findings in hemodialysis patients.

Methods

This was a single-center, cross-sectional study. Patients were divided into two groups according to mid-week inter-dialytic weight gain (mIDWG): (1) mIDWG ≤3% and (2) mIDW >3%.

Results

A total of 55 patients were enrolled in this study. While the mean pAGT and left ventricular mass index were significantly higher in patients with mIDWG >3% compared to patients with mIDWG ≤3%, VEGF-C was similar between groups. pAGT ≥76.8 mcg/L, VEGF-C ≤175.5 pg/ML, and pAGT /VEGF-C ≥0.45 were significant cut-offs for the prediction of left ventricular hypertrophy(LVH). Univariate logistic regression analysis revealed that these cut-off values were significantly associated with LVH.

Conclusion

Renin-angiotensin-aldosterone system activation may persist in hemodialysis patients with excessive IDWG. Additionally, pAGT and VEGF-C could be risk factors for the development of LVH.

CONFLICT OF INTEREST STATEMENT

The authors have no conflicts of interest to declare.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.